Table 5.
Morphological features, exocrine and endocrine insufficiency, and disability by race among subjects with chronic pancreatitis
| N (%) | All (N=1,159) |
Alcohol (N=572) |
Other (N=587) |
|||
|---|---|---|---|---|---|---|
| Black (N=248) | White (N=911) | Black (N=191) | White (N=381) | Black (N=57) | White (N=530) | |
| Calcifications | 157 (63.3)* | 503 (55.2) | 140 (73.3)* | 236 (61.9) | 17 (29.8) | 267 (50.4)* |
| Pseudocysts | 86 (34.7) | 258 (28.3) | 75 (39.3) | 153 (40.2) | 11 (19.3) | 105 (19.8) |
| Pancreatic atrophy | 107 (43.2)* | 315 (34.6) | 90 (47.1)* | 134 (35.2) | 17 (29.8) | 181 (34.2) |
| Pancreatic duct stricture or dilation | 180 (72.6)* | 597 (65.5) | 140 (73.3) | 251 (65.9) | 40 (70.2) | 346 (65.3) |
| Pancreatic duct irregularities | 130 (52.4)* | 220 (24.2) | 104 (54.5)* | 93 (24.4) | 26 (45.6)* | 127 (24.0) |
| Common bile duct stricture | 46 (18.6)* | 75 (8.2) | 43 (22.5)* | 46 (12.1) | 3 (5.3) | 29 (5.5) |
| Common bile duct dilatation | 61 (24.6)* | 125 (13.7) | 54 (28.3)* | 69 (18.1) | 7 (12.3) | 56 (10.6) |
| Exocrine insufficiency | 100 (40.3) | 325 (35.7) | 79 (41.4) | 148 (38.9) | 21 (36.8) | 177 (33.4) |
| Endocrine insufficiency | 99 (39.9)* | 275 (30.2) | 75 (39.3)* | 118 (31.0) | 24 (42.1) | 157 (29.6) |
| Disability | 87 (35.1)* | 195 (21.4) | 69 (36.1)* | 97 (25.5) | 18 (31.6)* | 98 (18.5) |
*
P value <0.05.